(Q36445884)
Statements
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma (English)
Linfeng Chen
John Daley
Wen Chen
Thomas E Witzig
Thomas M Habermann
Jeffery L Kutok
15 November 2007